Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2025-12-31 @ 12:36 AM
Study NCT ID:
NCT01346592
Status:
COMPLETED
Last Update Posted:
2015-03-26
First Post:
2011-04-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to < 72 Months of Age
Sponsor:
Novartis Vaccines
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-04
Start Date Type:
None
Primary Completion Date:
2012-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-07
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-30
First Submit QC Date:
None
Study First Post Date:
2011-05-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-01-27
Results First Submit QC Date:
None
Results First Post Date:
2014-05-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-11-22
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-03-04
Last Update Post Date:
2015-03-26
Last Update Post Date Type:
ESTIMATED